CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients

por Parczewski, M, Leszczyszyn-Pynka, M, Bander, D, Urbañska, A, Kaczmarczyk, M, Ciechanowicz, S, Boron-Kaczmarska, A
Publicado 2010